Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Advisor Pro Platform

K-Number: K210561 · 2021-09-28

Decision Date2021-09-28
Product CodeQCC
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

Advisor Pro Platform is a medical device manufactured by DreaMed Diabetes, Ltd.. It received FDA 510(k) clearance on 2021-09-28 under approval number K210561. The device is classified under product code QCC. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Advisor Pro Platform?

Advisor Pro Platform is a medical device that received FDA 510(k) clearance on 2021-09-28. It is manufactured by DreaMed Diabetes, Ltd.. The 510(k) number is K210561.

When was Advisor Pro Platform approved by the FDA?

Advisor Pro Platform received FDA 510(k) clearance on 2021-09-28, under approval number K210561.

What company makes Advisor Pro Platform?

Advisor Pro Platform is manufactured by DreaMed Diabetes, Ltd..

What is the FDA product code for Advisor Pro Platform?

The FDA product code for Advisor Pro Platform is QCC.

Other Devices by DreaMed Diabetes, Ltd.

Related Devices (Code: QCC)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.